![Structure of [(1R)-1-[[(2S,3R)-3-Hydroxy-2-[[(6-phenylpyridin-2-yl)carbonyl]amino]-1-oxobutyl]amino]-3-methylbutyl]boronic acid](https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?cid=24800541&t=l)
[(1R)-1-[[(2S,3R)-3-Hydroxy-2-[[(6-phenylpyridin-2-yl)carbonyl]amino]-1-oxobutyl]amino]-3-methylbutyl]boronic acid
[(1R)-1-[[(2S,3R)-3-hydroxy-2-[(6-phenylpyridine-2-carbonyl)amino]butanoyl]amino]-3-methylbutyl]boronic acid
Delanzomib is a C-terminal boronic acid peptide inhibitor which induces apoptosis in multiple myeloma, hematological and solid tumor cell lines. It has a role as an antineoplastic agent, a proteasome inhibitor and an apoptosis inducer. It is a C-terminal boronic acid peptide, a threonine derivative, a secondary alcohol and a phenylpyridine. It is functionally related to a L-threonine.
Source: ChEBIDisclaimer: The information above is provided for general reference purposes only. Applications, dosage, handling procedures and suitability for any specific use must be determined solely by the user based on their own assessment. This information does not constitute a recommendation or endorsement for any particular application and should not be used as the basis for product selection.
| Catalog No. | 847499278 |
|---|---|
| CAS Number | 847499-27-8 |
| IUPAC Name | [(1R)-1-[[(2S,3R)-3-hydroxy-2-[(6-phenylpyridine-2-carbonyl)amino]butanoyl]amino]-3-methylbutyl]boronic acid |
| Purity | 98% |
| SMILES | O[C@@H]([C@@H](C(=O)N[C@@H](CC(C)C)B(O)O)NC(=O)C1=NC(=CC=C1)C1=CC=CC=C1)C |
Certificate of Analysis (COA)
Batch-specific analytical results confirming purity, identity, and quality.
Safety Data Sheet (SDS)
GHS-compliant safety information including hazards, handling, and disposal.
This product is not classified as a hazardous material under standard shipping regulations.
For complete safety information, always refer to the product's Safety Data Sheet.